Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
WELL Health Technologies Corp
T.WELL.DB
Primary Symbol:
T.WELL
Alternate Symbol(s):
WHTCF
Healthcare
WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and...
Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:WELL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(49)
•••
wideopenthrottl
X
View Profile
View Bullboard History
Comment by
wideopenthrottl
on Mar 26, 2024 3:06pm
RE:$900 marketcap
nice to have owned a pot stock for this last run (imho based on speculation of the fed moving a bit)...i have been out of Tilray for a long time and missed this nice pop...Glad to hear you were in on
...more
(68)
•••
Magnitude
X
View Profile
View Bullboard History
Post by
Magnitude
on Mar 26, 2024 2:52pm
$900 marketcap
Heres the difference between 2 companies both with $900 million marketcap, just shows what a difference hype can do (I own both) WEED.TO mktcap $900 million 12 analyst target $5.39 CAD
...more
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(130)
•••
Tradinghands
X
View Profile
View Bullboard History
Post by
Tradinghands
on Mar 26, 2024 2:08pm
Its great seeing positive movement
Looks like buying in is already paying off. GLTA
(40)
•••
Dogsbreakfast4U
X
View Profile
View Bullboard History
Comment by
Dogsbreakfast4U
on Mar 26, 2024 1:30pm
RE:RE:RE:WELL.T POSSIBLE GAP UP AT OPEN
He said at the open.
(27)
•••
Yanner911
X
View Profile
View Bullboard History
Comment by
Yanner911
on Mar 26, 2024 12:19pm
RE:RE:RE:Maxim rating
Free cadh flow to fund growth. Slow the f down dillution and no more dept.
(45)
•••
Mikerich
X
View Profile
View Bullboard History
Comment by
Mikerich
on Mar 26, 2024 11:57am
RE:RE:WELL.T POSSIBLE GAP UP AT OPEN
No he meant gap up, which it did at $3.71 open, and now some follow through....GLTA
(160)
•••
Charts1
X
View Profile
View Bullboard History
Post by
Charts1
on Mar 26, 2024 11:54am
WELL.T ANOTHER UPGRADE
https://www.stocktargetadvisor.com/stock/Canada/TSX/WELL
(160)
•••
Charts1
X
View Profile
View Bullboard History
Post by
Charts1
on Mar 26, 2024 11:53am
WELL.T BREAKING OUT OVER THE 200 DMA
https://www.tradingview.com/x/Y6s6wm88/
(160)
•••
Charts1
X
View Profile
View Bullboard History
Post by
Charts1
on Mar 26, 2024 11:50am
WELL..T ON THE MOVE
/
(68)
•••
Magnitude
X
View Profile
View Bullboard History
Post by
Magnitude
on Mar 26, 2024 11:48am
Could you imagine?
While we're all looking for organic growth from WELL which will be bullish out of the blue a larger US healthcare company offers to buy WELL for Canadian exposure? I'm not saying that it will
...more
(62)
•••
Steve33
X
View Profile
View Bullboard History
Post by
Steve33
on Mar 26, 2024 11:09am
Interference
Thought we would be up today. The stock suppression doesnt seem to be here today and the market is green.
(791)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Mar 26, 2024 10:56am
Still in🐶
the dog house
(62)
•••
82Supra
X
View Profile
View Bullboard History
Comment by
82Supra
on Mar 26, 2024 10:50am
RE:RE:Maxim rating
??
(27)
•••
Yanner911
X
View Profile
View Bullboard History
Comment by
Yanner911
on Mar 26, 2024 10:46am
RE:Maxim rating
Fcf
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study